How to Analyse an IPO Before Applying: 7-Parameter Framework

Every IPO season brings a familiar story. A company announces its IPO, social media starts discussing listing gains, GMP (Grey Market Premium) screenshots begin circulating, and many investors rush to apply without understanding the business.

Sometimes this might works. Many times, it doesn't.

The reality is that an IPO is not a lottery ticket. When you apply for an IPO, you are becoming a shareholder in a business. The quality of that business ultimately matters far more than short-term hype.

The good news is that you don't need to be a professional analyst to evaluate an IPO. By focusing on a few important factors from the company's DRHP (Draft Red Herring Prospectus), you can separate strong opportunities from risky ones.

Let's look at a simple 7-parameter framework that can help you analyse almost any IPO.

The Biggest Mistake Investors Make While Analysing IPOs

Many investors analyse IPOs in the wrong order. Instead of starting with the business, they often start with questions like:

• What is the GMP?
• How much is the subscription?
• Are people talking about it on social media?

While these factors can provide useful information, they do not tell you whether the company is fundamentally strong.

Imagine buying a house because a crowd is gathered outside without checking the location, construction quality, or price. The crowd may tell you that the property is popular, but it does not tell you whether it is worth buying.

The same principle applies to IPOs.

An IPO is ultimately an opportunity to invest in a business. The long-term outcome depends far more on factors such as the company's business model, financial health, competitive position, management quality, growth prospects, and valuation than on short-term market excitement.

That's why experienced investors typically analyse the business first and market sentiment later.

The 7-parameter framework below follows the same approach, helping you evaluate an IPO in a structured and logical way before making an application decision.

Parameter 1: Business Quality & Competitive Moat

Before looking at financial numbers, first understand the business itself.

Ask three simple questions:

• What does the company actually do?
• Is the industry growing?
• What prevents competitors from easily copying the business?

This last question is called a moat.

A moat is a durable competitive advantage that protects a company from competition.

For example:

• A strong brand can be a moat.
• A large distribution network can be a moat.
• Regulatory approvals can be a moat.
• Proprietary technology can be a moat.

Think of a local tea stall and a nationwide brand.

Anyone can open a tea stall. Very few can build a trusted brand with thousands of outlets across the country. The stronger the moat, the harder it becomes for competitors to take market share.

Also look at industry growth. Even a well-run company can struggle if it operates in a shrinking market. On the other hand, companies participating in rapidly growing industries often benefit from industry tailwinds.

Parameter 2: Financial Health - Revenue, Profit, Cash Flow

Once the business makes sense, the next step is understanding its financial health.

The last three years of financial data in the DRHP often reveal whether the company is genuinely improving or simply benefiting from temporary factors.

Revenue Trajectory: 3-Year CAGR

Revenue is the money generated from selling products or services.

Instead of focusing on one good year, look at the three-year trend. A company whose revenue consistently grows over multiple years is generally more reliable than one that suddenly reports a sharp jump just before the IPO.

For example:

• FY24 Revenue: ₹500 crore
• FY25 Revenue: ₹650 crore
• FY26 Revenue: ₹850 crore

This shows a steady growth trajectory. Consistent growth usually indicates increasing demand, market expansion, or successful execution.

One-year spikes should always be investigated carefully.

Profitability: Pre-profit vs Post-profit

Not all IPO companies are profitable. Some are already generating profits, while others are still investing heavily for future growth. Neither is automatically good or bad.

However, investors should understand the difference.

A profitable company has already demonstrated its ability to convert revenue into earnings. A loss-making company is asking investors to trust future profitability. That introduces additional risk.

When analysing profitability, look for:

• Profit growth trend
• Operating margin trend
• Consistency of earnings

The longer a company remains unprofitable, the more important it becomes to understand its path to profitability.

Operating Cash Flow > Net Profit = Healthy Sign

This is one of the most overlooked indicators. Profit can be influenced by accounting adjustments. Cash flow is harder to manipulate.

Operating cash flow shows the actual cash generated from day-to-day business operations.

A simple rule: If operating cash flow is consistently equal to or higher than net profit, it is usually a healthy sign.

For example:

• Net Profit: ₹100 crore
• Operating Cash Flow: ₹130 crore

This suggests the company is actually collecting cash from customers.

On the other hand, if profits keep rising while cash flow remains weak, investors should investigate further.

Cash flow often reveals problems before profit numbers do.

Parameter 3: Valuation vs Listed Peers (P/E, EV/EBITDA, P/S)

A great company can still become a poor investment if bought at an excessive valuation. That's why valuation matters.

The most common valuation metric is the Price-to-Earnings (P/E) ratio, which tells you how much investors are paying for every ₹1 of profit.

For example:

• IPO P/E = 50x
• Listed competitors trade at 25x

This means investors are paying twice as much for the IPO's earnings compared to similar listed companies.

That premium may be justified if the company is growing much faster than its peers. But if growth rates are similar, the IPO could be expensive.

For companies with low or fluctuating profits, analysts often use EV/EBITDA. It compares the total business value with its operating earnings before interest, taxes, depreciation, and amortisation.

For example:

• IPO EV/EBITDA = 30x
• Peer average = 18x

Again, investors are paying a significant premium, so there should be a strong reason behind it.

For loss-making startups that have little or no profit, investors often look at the Price-to-Sales (P/S) ratio, which compares a company's valuation with its revenue.

For example:

• IPO P/S = 12x
• Listed peers = 6x

This means investors are paying ₹12 for every ₹1 of revenue, versus ₹6 for comparable companies.

A higher P/S ratio suggests investors expect stronger future growth and eventual profitability. But revenue alone does not create shareholder value. What ultimately matters is whether the company can eventually convert those sales into profits and cash flows.

You don't need to become an expert in valuation formulas. The key question is simple:

Is the IPO asking investors to pay significantly more than comparable listed companies?

If yes, there should be a clear reason, such as faster growth, stronger margins, a larger market opportunity, or a durable competitive advantage.

Parameter 4: Objects of the Issue - Growth Capital vs Promoter Exit

One of the most important sections of the DRHP is "Objects of the Issue". This tells investors how the IPO money will be used.

Generally, fresh issue proceeds used for:

• Capacity expansion
• New factories
• Technology investments
• Debt reduction
• Business growth

are viewed positively because the company receives the money.

Now compare that with an Offer for Sale (OFS).

In an OFS, existing shareholders sell their shares and keep the money. The company receives nothing.

This does not automatically make an IPO bad. However, investors should ask: Why are shareholders selling?

A balanced mix of fresh issue and OFS is common. But when an IPO is heavily dominated by OFS, it deserves closer scrutiny.

Parameter 5: Promoter Credibility & Post-IPO Holding

Investors are not just investing in a business. They are also investing in the people running it.

Look at:

• Promoter background
• Industry experience
• Corporate governance record
• Regulatory issues, if any

The DRHP contains detailed information on these aspects.

Another useful indicator is promoter shareholding after the IPO. A high post-IPO stake often signals continued commitment to the business. If promoters significantly reduce their ownership, investors should understand the reasons carefully.

Context matters. A small stake reduction may be normal. A large reduction may require additional investigation.

Parameter 6: Understand GMP, But Don't Rely on It

GMP (Grey Market Premium) is the unofficial premium at which IPO shares trade before listing in the grey market.

It is important to understand that the grey market is unregulated, operates outside the formal stock exchange system, and is not monitored by SEBI. The reported GMP figures may not be transparent or verifiable.

Many investors use GMP to judge an IPO's attractiveness. However, GMP does not tell you anything about the company's business quality, financial health, management, growth prospects, or valuation.

Think of GMP as a measure of short-term market excitement, not business strength.

A company with a high GMP can still be overvalued, while a company with a low GMP can still be fundamentally strong.

This is why informed investors typically analyse the business, financials, valuation, promoters, and use of IPO proceeds first. GMP, if considered at all, should be viewed only as a market sentiment indicator and not as a basis for an investment decision.

Parameter 7: Subscription - QIB Demand Is the Strongest Signal

Once bidding starts, subscription data becomes important.

Not all subscription categories carry equal weight. The category most investors should watch is QIB. QIB stands for Qualified Institutional Buyers.

This includes:

• Mutual funds
• Insurance companies
• Pension funds
• Foreign institutional investors

These institutions have dedicated research teams and access to management interactions. They typically perform extensive due diligence before investing.

Therefore, strong QIB participation often acts as an important validation signal.

For example:

• Retail: 20x
• NII: 40x
• QIB: 1x

This is not as encouraging as:

• Retail: 8x
• NII: 12x
• QIB: 25x

Institutional demand often carries greater informational value than retail enthusiasm.

Of course, it is not a guarantee of success, but it is one of the strongest signals available before listing.

IPO Analysis Scorecard: All 7 Parameters at a Glance

A simple interpretation framework:

The score should not replace analysis. It simply helps organise your thinking.

Which IPO Is Best to Buy? Applying the Framework

Many investors search:

• Which IPO is best?
• Which IPO is best to buy today?

The truth is that there is no universally "best" IPO.

An IPO that looks attractive today may look expensive tomorrow if valuation changes. Instead of searching for the best IPO, focus on finding IPOs that score well across multiple parameters.

For example:

Suppose an IPO has:

• Strong industry growth
• Consistent revenue growth
• Healthy cash flows
• Reasonable valuation
• Fresh issue focused on expansion
• High promoter ownership
• Strong QIB demand

Even if market sentiment around the IPO is muted, a fundamentally strong business may still be worth evaluating on its own merits.

On the other hand, an IPO with:

• Weak cash flow
• Expensive valuation
• Large OFS component
• Falling profits

may remain risky despite strong market excitement around the IPO.

This is why successful IPO investing is usually less about predicting listing gains and more about evaluating business quality.

The best IPO is rarely the one creating the most noise. More often, it is the one that quietly scores well across the fundamentals that truly matter.